Literature DB >> 29590535

Things We "kNOw" and Do Not "kNOw" about Pulmonary Hypertension.

Jarrod W Barnes1,2, Rakesh P Patel3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29590535      PMCID： PMC6058978          DOI： 10.1164/rccm.201803-0424ED

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  26 in total

1.  O-linked β-N-acetylglucosamine transferase directs cell proliferation in idiopathic pulmonary arterial hypertension.

Authors:  Jarrod W Barnes; Liping Tian; Gustavo A Heresi; Carol F Farver; Kewal Asosingh; Suzy A A Comhair; Kulwant S Aulak; Raed A Dweik
Journal:  Circulation       Date:  2015-02-06       Impact factor: 29.690

2.  An official American Thoracic Society Statement: pulmonary hypertension phenotypes.

Authors:  Raed A Dweik; Sharon Rounds; Serpil C Erzurum; Stephen Archer; Karen Fagan; Paul M Hassoun; Nicholas S Hill; Marc Humbert; Steven M Kawut; Michael Krowka; Evangelos Michelakis; Nicholas W Morrell; Kurt Stenmark; Rubin M Tuder; John Newman
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

3.  Nitric oxide synthase in pulmonary hypertension: lessons from knockout mice.

Authors:  K A Fagan; I McMurtry; D M Rodman
Journal:  Physiol Res       Date:  2000       Impact factor: 1.881

4.  Rescue Treatment with L-Citrulline Inhibits Hypoxia-Induced Pulmonary Hypertension in Newborn Pigs.

Authors:  Candice D Fike; Anna Dikalova; Mark R Kaplowitz; Gary Cunningham; Marshall Summar; Judy L Aschner
Journal:  Am J Respir Cell Mol Biol       Date:  2015-08       Impact factor: 6.914

Review 5.  Pulmonary Arterial Hypertension: Diagnosis and Treatment.

Authors:  Christopher F Barnett; Paulino Alvarez; Myung H Park
Journal:  Cardiol Clin       Date:  2016-08       Impact factor: 2.213

6.  Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3.

Authors:  W Steudel; M Scherrer-Crosbie; K D Bloch; J Weimann; P L Huang; R C Jones; M H Picard; W M Zapol
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

7.  Role of nitric oxide in the local regulation of pulmonary vascular resistance in humans.

Authors:  C J Cooper; M J Landzberg; T J Anderson; F Charbonneau; M A Creager; P Ganz; A P Selwyn
Journal:  Circulation       Date:  1996-01-15       Impact factor: 29.690

Review 8.  Soluble Guanylate Cyclase Stimulators and Activators: Novel Therapies for Pulmonary Vascular Disease or a Different Method of Increasing cGMP?

Authors:  Cody Koress; Kevin Swan; Philip Kadowitz
Journal:  Curr Hypertens Rep       Date:  2016-04       Impact factor: 5.369

9.  Nitrate and nitrite in biology, nutrition and therapeutics.

Authors:  Jon O Lundberg; Mark T Gladwin; Amrita Ahluwalia; Nigel Benjamin; Nathan S Bryan; Anthony Butler; Pedro Cabrales; Angela Fago; Martin Feelisch; Peter C Ford; Bruce A Freeman; Michael Frenneaux; Joel Friedman; Malte Kelm; Christopher G Kevil; Daniel B Kim-Shapiro; Andrey V Kozlov; Jack R Lancaster; David J Lefer; Kenneth McColl; Kenneth McCurry; Rakesh P Patel; Joel Petersson; Tienush Rassaf; Valentin P Reutov; George B Richter-Addo; Alan Schechter; Sruti Shiva; Koichiro Tsuchiya; Ernst E van Faassen; Andrew J Webb; Brian S Zuckerbraun; Jay L Zweier; Eddie Weitzberg
Journal:  Nat Chem Biol       Date:  2009-12       Impact factor: 15.040

Review 10.  The Wonders of Phosphodiesterase-5 Inhibitors: A Majestic History.

Authors:  A S Elhwuegi
Journal:  Ann Med Health Sci Res       Date:  2016 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.